Latham & Watkins Advises Lead Investor in evolvedMD’s US$34 Million Series B

evolvedMD, a collaborative care management provider, has announced the close of its US$34 million Series B investment led by Sustainable Investing at Goldman Sachs Alternatives. Existing investors also participated in the round.

Latham & Watkins LLP represents Goldman Sachs Alternatives in the transaction with a corporate deal team led by Bay Area partner Saad Khanani, with associates Omar Ammash and Aubrey Thompson Jr. Advice was also provided on healthcare matters by Washington, D.C. partner Jason Caron, with associate Margaret Rote; on data privacy matters by Bay Area partner Heather Deixler, with associates Zac Alpert and Ryleigh Chen; on intellectual property matters by Bay Area counsel Josh Real, with associate Caroline Omotayo; on ESG matters by New York partner Betty Huber and London counsel Anne Mainwaring, with associate Jaime Martin; and on tax matters by Bay Area partner Grace Lee and Century City/Bay Area partner Julie Crisp, with associate Gregory Conyers.